Clinical trial to evaluate thehepatoprotective effect of Liv-Ever (Punarnava – Boerhaviadiffusa -tablet)
Phase 2
- Conditions
- Health Condition 1: K70-K77- Diseases of liver
- Registration Number
- CTRI/2023/08/057144
- Lead Sponsor
- niversity of Kerala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects of either gender with an age group between 18 - 70 years
Subjects having elevated liver enzymes panel due to multiple causes like obesity, hyper
triglyceridemia, drug induced liver disease etc.
Subjects with fluctuating liver enzyme panel due to unknown reasons.
Subjects who are willing to sign the informed consent form
Exclusion Criteria
Patients with chronic liver diseases
Pregnant and lactating women
Suspected malignant conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method